Creative Planning’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,136
| Closed | -$52.1K | – | 3751 |
|
|
2024
Q4 | $52.1K | Buy |
17,136
+6,278
| +58% | +$19.1K | ﹤0.01% | 3231 |
|
|
2024
Q3 | $56.4K | Buy |
+10,858
| New | +$56.4K | ﹤0.01% | 3083 |
|
|
2024
Q2 | – | Sell |
-11,551
| Closed | -$56.8K | – | 3100 |
|
|
2024
Q1 | $56.8K | Buy |
+11,551
| New | +$56.8K | ﹤0.01% | 2756 |
|
|
2023
Q2 | – | Sell |
-53
| Closed | -$1.71K | – | 2730 |
|
|
2023
Q1 | $1.71K | Buy |
+53
| New | +$1.71K | ﹤0.01% | 2444 |
|
|
2021
Q4 | – | Sell |
-9,113
| Closed | -$254K | – | 2178 |
|
|
2021
Q3 | $254K | Hold |
9,113
| – | – | ﹤0.01% | 1696 |
|
|
2021
Q2 | $270K | Sell |
9,113
-23
| -0.3% | -$681 | ﹤0.01% | 1612 |
|
|
2021
Q1 | $255K | Buy |
+9,136
| New | +$255K | ﹤0.01% | 1870 |
|
|
2017
Q3 | – | Sell |
-1,000
| Closed | -$26K | – | 3707 |
|
|
2017
Q2 | $26K | Buy |
1,000
+900
| +900% | +$23.4K | ﹤0.01% | 2977 |
|
|
2017
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 4242 |
|
|
2016
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 4197 |
|